跳到正文
研踪PaperTrail

论文库

检索计算机领域论文,按研究方向、作者或关键词筛选。

部分采集异常
正在读取账号与研究记录…

全站更新概况

+1084新增论文
+883其中 AI 相关
+130已有论文修订
+59新增 AI 导读

arXiv 最近完成扫描:2026-11-18 04:28 · 全站最近入库:2026-11-18 19:45各信源进度 →

统计口径与数据新鲜度

统计 2026-11-17 23:55 — 2026-11-18 23:55(北京时间) · 点击数字查看对应简报;AI 相关包含在新增论文内。

最近完成检查:2026-11-18 04:28最近发现新增版本:2026-11-18 19:45库内论文最新更新时间:2026-11-18 08:00

每分钟刷新已保存的数据。空检查不代表采集异常;新收录可能包含历史论文。AI 导读按新增版本计数。

26,870 已收录论文22,374 AI 相关8,156 有修订112 HF 社区发现

浏览论文库

时间范围跟随排序:版本更新、本站收录或首次发表。最新收录可能包含历史论文。部分信源异常,查看状态 →

找到 1 篇论文 · 按版本更新时间排序上轮扫描起点 2026-11-18 04:27(北京时间)
版本更新 · v2arXiv:2510.10196

A Subspecialty Diagnostic System Powered by Self-Supervised Learning for Cervical Histopathology

Yizhi Wang, Li Chen, Qiang Huang, Tian Guan, Xi Deng, Zhiyuan Shen, Jiawen Li, Xinrui Chen 等 30 位作者

原文摘要

Cervical cancer remains a major malignancy in women, with large-scale human papillomavirus-based screening generating a large volume of biopsies and, for advanced cases, surgical specimens, imposing an overwhelming diagnostic burden that necessitates precise histopathological evaluation. Although deep learning shows promise, general foundation models offer a broader reach but remain limited in capturing subspecialty-specific features and task adaptability. We introduce the Cervical Subspecialty Pathology (CerS-Path) diagnostic system, built upon the subspecialized dataset and developed through two synergistic pretraining stages: self-supervised learning on approximately 190 million tissue patches to build a cervical-specific feature extractor, and multimodal enhancement with 2.5 million image-text pairs, followed by diagnostic functions integration and downstream task enhancement. CerS-Path integrates eight functions -- across morphological diagnosis, predictive analytics, and multimodal tasks -- to cover the diagnostic workflow from biopsies to resection specimens. Comprehensive evaluations demonstrate improved performance in cervical pathology in female patients, where CerS-Path outperforms state-of-the-art foundation models across 26 of 30 diagnostic tasks. Furthermore, in multicenter retrospective and prospective validation across six independent cohorts of women, CerS-Path achieves up to 99% sensitivity for clinically relevant lesion detection with acceptable specificity across sites, highlighting its potential for screening-derived histopathology and suitability for integration into high-volume diagnostic pathways.

cs.CV